Jacob Minnig
Jacob Minnig
"Psychedelic Therapy in the Future of Healthcare" Interview with Sofia Peeva, M.D. Christopher Fischer, M.D. Jordan A. Dobrowski, LCSW, and Ryan Paul, Phd
"Psychedelic Therapy in the Future of Healthcare" Interview with Sofia Peeva, M.D. Christopher Fischer, M.D. Jordan A. Dobrowski, LCSW, and Ryan Paul, Phd
"Psychedelic Therapy in the Future of Healthcare" Interview with Sofia Peeva, M.D. Christopher Fischer, M.D. Jordan A. Dobrowski, LCSW, and Ryan Paul, Phd
Monday 31st July 2023
Explore the future of psychedelic therapy and its potential integration into mainstream healthcare with experts in this insightful episode.
Explicit
76 minutes
Informative
Empowering
Inspiring
Hopeful
Supportive
About this podcast
Author:
Jacob Minnig
Overview:
Categories:
Innovative Treatments & Recovery Paths
Sobriety Toolkit
Innovative Healing Arts
Mindfulness & Emotional Wellbeing
Navigating Intimate Relationships
Links:
Visit site
Episodes:
132 (View all)
Do you want to link to this podcast?
Get the buttons here!Psychedelic Therapy: A New Frontier in Healthcare
Episode Overview
- Exploration of the future of psychedelic interventions and the potential integration of psychedelic-assisted therapies into the healthcare system
- Insights into managed care, healthcare system reimbursement, and urgent healthcare challenges
- Discussion on the role of pharmacogenomics in mental and behavioral health
- Collaborative approach to revolutionize primary mental health and addiction treatment
- Considerations for the future of mental health in the healthcare system
The era of mental health being a chemical imbalance is kind of coming to an end... I don't see ketamine as a psychedelic assisted therapy, as in my personal experience, I just see it as plant medicine.
Imagine a world where psychedelic therapy isn't just a fringe idea but a mainstream healthcare option. In this episode of 'Behavioral Health Integration', host Jacob Minnig sits down with a panel of experts—Sofia Peeva, M.D., Christopher Fischer, M.D., Jordan A. Dobrowski, LCSW, and Ryan Paul, PhD—to explore the groundbreaking potential of psychedelic-assisted therapies. They dive into how these treatments could be integrated into existing healthcare systems and what that means for patients and providers alike.
From reimbursement rates to the challenges of equitable access, the discussion covers a lot of ground. You'll hear about the urgent healthcare issues that need addressing and how a collaborative approach can make high-quality care more accessible to vulnerable populations. If you're curious about the future of mental health treatment and how psychedelics might play a role, this episode is a must-listen.